NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 20, 2024 $0.105 +6.99% $0.0980 X 93.01% 0
Feb 20, 2024 $0.102 +4.37% $0.0980 X 95.63% 0
Feb 16, 2024 $0.114 +6.37% $0.0980 X 83.75% 0
Feb 16, 2024 $0.111 +3.98% $0.0980 X 86.36% 0
Feb 9, 2024 $0.130 +6.68% $0.125 V 95.46% 1
Feb 9, 2024 $0.127 +4.18% $0.125 V 97.91% 1
AlexVel AlexVel Pro
Feb 9, 2024 $0.121 -0.54% $0.125 X 97.46% 0
AlexVel AlexVel Pro
Feb 8, 2024 $0.111 -2.88% $0.122 X 91.07% 0
Feb 8, 2024 $0.123 +7.34% $0.122 V 99.35% 4
Feb 8, 2024 $0.120 +4.59% $0.122 V 98.07% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE